-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Grants Fast Track Designation to Innovent's IBI3003 for Relapsed or Refractory Multiple Myeloma

Reuters·01/27/2026 00:00:21

Please log in to view news